Reagents and Instrumentation
Lipoic acid, propargylamin, DCC, NHS and other chemicals were analytic reagents and used as received without any purification. Ultrapure water (18 MΩ) from a Millipore system was used to prepare solutions throughout the assay. BSA (bovine serum albumin) was purchased from SigmaAldrich. 96-well polystyrene plates were purchased from Corning Incorporated. Human 
Preparation of functionalized AuNPs
Synthesis of compound 1 [1] . A solution of DCC (0.5 g, 2.5 mmol) in 3 mL dichloromethane was added to an ice-cooled solution of lipoic acid (0.5 g, 2 mmol) and N-hydroxysuccinimde (0.23 g, 2 mmol) in 4 mL dichloromethane. To fully precipitate dicyclohexylurea (DCU), the solution was placed in refrigerator overnight after stirring for 1 h. The filtrate was obtained after filtration of the precipitate and then was evaporated in vacuo. Yellowish solid was formed after using diethyl ether to treat with the residue and then was washed with ether. Thus the pure product of compound 2 was obtained. To synthesize compound 1, compound 2 (0.5 g, 1.56 mmol) was dissolved in 10 mL dichloromethane, and then added drop-wise an ice cold solution of propargylamine (100 μL 1.56 mmol) in dichloromethane. The resulting solution was diluted with 30 mL dichloromethane and saturated sodium carbonate after stirring for 3 h. The organic layer was washed three times with saturated brine, dried with anhydrous sodium sulfate over then evaporated to dryness. Subsequently the obtained residue was purified by silica gel column chromatography. Figure S1 -S3 are the characterization of the target compound.
Synthesis of AuNPs.
AuNPs were prepared by the citrate-induced reduction of HAuCl 4 . In a 100 mL round bottom flask, 50 mL of 0.01 wt% HAuCl 4 was heated to rolling boil to reflux with vigorous stirring. Addition of 5 mL of 38.8 mM sodium citrate resulted in a color change of the solution from pale yellow to red. Heating was continued for 15 min and then removed while the stirring was kept for another 15 min. The resulting solution was allowed to cool to room temperature and then characterized by UV-Vis spectrometer. The synthesized AuNPs was stored at 4℃ in a centrifuge tube.
Preparation of terminal alkyne-functionalized AuNPs. 200 μL solution of compound 1(1 mM in ethanol) was added drop-wise to 10 mL Au colloid, using sodium hydroxide to adjust the basicity of the solution to pH 9. The resulting solution was stirred for 24 h under room temperature and then was centrifuged for 20 min (9000 rpm) to remove the excess compound 1. The obtained alkynefunctionalized AuNPs was washed with water for three times, redispersed in distilled water and then stored in a refrigerator at 4℃. Figure S1 . UV-Vis spectra of bare AuNPs and alkyne-functionalized AuNPs. As we can see, there is a slightly red shift in UV spectra after functionalization. 
Preparation of antibody labeled AgNPs
Synthesis of 70-nm AgNPs. Silver nanoparticles were prepared according to a classic method. 18
mg AgNO 3 were dissolved in 100 mL distilled water, heated to boil with vigorous stirring. 2 mL 1% sodium citrate was added in the boiling solution and continued heating for 30 min. The Ag sols were stored in dark bottles after cooling to room temperature. Combination of AgNPs to antibody. We prepared the antibody labeled Ag nanoparticle by using electrostatic adhesion method, which is similar with the commercialized product (gold nanoparticle labeled with antibody). Thus, the robustness and universal of our functionalization is unquestionably good. In detail, the synthesized silver nanoparticles were condensed using centrifugation and finally dispersed in 10 mM (or lower) PBS (pH 7.4, avoiding chloridion), to which 1 mL antibody was added in quickly. The mixed solution was shaked for 12 h and then blocked for another 12 h with 500 μL 1% BSA. The solution was repeatedly centrifuged under optimized conditions to get rid of the excess antibody and silver nanoparticles. AgNPs-AB (AgNPs conjugated with antibody) was dispersed in 0.1% BSA (20 mM PBS with 150 mM Cl -1 ) and then stored at 4℃. Note that, the concentration of silver nanoparticles should be higher than that of the detected antigen.
The reason for choosing 70 nm Ag nanoparticles is a compromise of sensitivity and practicability.
Although larger diameter of Ag nanoparticles would produce higher sensitivity, lager Ag nanoparticles with uniform shape and size is difficult to synthesis and is hardly adapted into immunosorbent assay because of the less stable suspension. The diameter of 70 nm is employed since it is enough for the sensitivity and it could easily suspend in the solution. 
The dissolution of

Enhanced MeLISA for AFP detection
Sandwich assay for AFP. 100 μL of capture antibody diluted 500 times in sodium bicarbonate (50 mM, pH 9.6) was added into each well of 96-well polystyrene plate, and then the plate was The incubation time for AgNP-AB. AgNP-AB was used to replace the enzyme-linked antibody in ELISA. Considering this difference, we optimized the incubation time for AgNP-AB. For this purpose, identical protocol was performed as "sandwich assay for AFP" (the concentration of AFP was 10 -8 g mL -1 ). As described in Figure S6 , within 40 min the specific antigen-antibody reaction was already reached maximum degree. The incubation time is similar to that in classic immunoassay. The amount of antibody adsorbed to silver nanoparticles. The concentration of antibody was optimized to better combine with silver nanoparticles in AFP detection. An AFP concentration of 10 -8 g mL -1 was used to he experiment. As depicted in Figure S7 , the concentration of antibody should be five times higher than that of AgNPs. In the following experiment, a concentration of antibody that of ten times AgNPs was used to do the combination. 
Enhanced MeLISA for CRP detection.
AgNPs with a diameter of 15 nm were prepared via sodium borohydride reduction. The 
The detection protocol for clinical samples
The serum samples were collected from patients with hepatocellular carcinoma and normal subjects, Table S3 . Concentrations of PSA in these sera obtain from the hospital. 
